Indian Immunologicals targets dengue vaccine launch by Jan 2026

Dengue, a mosquito-borne disease, has over the last few years become a major public health concern in India.

Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top executive said, as the race to develop the country’s first such vaccine heats up.